Success Metrics

Clinical Success Rate

75.0%

Based on 3 completed trials

Completion Rate

75%(3/4)

Active Trials

0(0%)

Results Posted

133%(4 trials)

Terminated

1(25%)

Phase Distribution

Ph phase_4

25%

Ph not_applicable

50%

Ph phase_2

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

1(25.0%)

Phase 4Post-market surveillance

1(25.0%)

N/ANon-phased studies

2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (25.0%)

Phase 41 (25.0%)

N/A2 (50.0%)

Trials by Status

completed375%

terminated125%

Recent Activity

0 active trials

Showing 4 of 4

terminatedphase_2

Study of Occipital Nerve Stimulation for Drug Refractory Migraine

NCT00747812

completednot_applicable

Treatment for Migraines With an Implantable Device

NCT00286078

completednot_applicable

Precision Versus Endurance Training to Improve Walking After Chronic Incomplete SCI

NCT01765153

completedphase_4

Effect of Pulse Width With Spinal Cord Stimulation

NCT00399516

Clinical Trials (4)

Showing 4 of 4 trials

NCT00747812Phase 2

Study of Occipital Nerve Stimulation for Drug Refractory Migraine

Terminated

NCT00286078Not Applicable

Treatment for Migraines With an Implantable Device

Completed

NCT01765153Not Applicable

Precision Versus Endurance Training to Improve Walking After Chronic Incomplete SCI

Completed

NCT00399516Phase 4

Effect of Pulse Width With Spinal Cord Stimulation

Completed

All 4 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 4